← Leaderboards
Nami McCarty
University Of Texas Hlth Sci Ctr Houston
$4,379,218
Attributed
$4,379,218
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $514.7K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,379,218 · 4
By mechanism
R01$3,387,770 · 1
R21$721,448 · 2
K22$270,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Bruce C. Kone$10,492,866
- Zhichao Xu$194,914
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularCellsPathologyIn VivoDrug ResistanceResistanceMalignant NeoplasmsB-LymphocytesStem CellsPathway InteractionsStemPlaySamplingChemotherapyRefractoryGene Expression ProfilingRelapseBiochemicalPathogenesisPreventAutophagocytosisBone MarrowReportingStress
Grant awards (16)
Analyzing protein homeostasis pathways in multiple myeloma stem-like cells$370,500
R01 · FY2025 · CA · contact PI
Analyzing protein homeostasis pathways in multiple myeloma stem-like cells$351,975
R01 · FY2024 · CA · contact PI
Analyzing protein homeostasis pathways in multiple myeloma stem-like cells$363,090
R01 · FY2023 · CA · contact PI
Analyzing protein homeostasis pathways in multiple myeloma stem-like cells$363,090
R01 · FY2022 · CA · contact PI
Analyzing protein homeostasis pathways in multiple myeloma stem-like cells$370,500
R01 · FY2021 · CA · contact PI
Targeting Stem-Cell Dependent Drug Resistance in Human MCL$313,723
R01 · FY2018 · CA · contact PI
Targeting Stem-Cell Dependent Drug Resistance in Human MCL$313,723
R01 · FY2017 · CA · contact PI
Delineating roles for a novel tri-protein complex (TRIM44) in the multiple myeloma stem cell niche$200,970
R21 · FY2017 · CA · contact PI
Targeting Stem-Cell Dependent Drug Resistance in Human MCL$313,723
R01 · FY2016 · CA · contact PI
Delineating roles for a novel tri-protein complex (TRIM44) in the multiple myeloma stem cell niche$167,475
R21 · FY2016 · CA · contact PI
Targeting Stem-Cell Dependent Drug Resistance in Human MCL$313,723
R01 · FY2015 · CA · contact PI
Targeting Stem-Cell Dependent Drug Resistance in Human MCL$313,723
R01 · FY2014 · CA · contact PI
Characterizing Clonogenic Populations in Mantle Cell Lymphoma$189,878
R21 · FY2011 · CA · contact PI
Characterizing Clonogenic Populations in Mantle Cell Lymphoma$163,125
R21 · FY2010 · CA · contact PI
Identification and characterization of molecules important in the immune system$108,000
K22 · FY2007 · AI · contact PI
Identification and characterization of molecules important in the immune system$162,000
K22 · FY2006 · AI · contact PI